DJIA 17,689.86 -56.12 -0.32%
NASDAQ 5,128.28 -0.50 -0.01%
S&P 500 2,103.84 -4.79 -0.23%
market minute promo

GlaxoSmithKline (NYSE: GSK)

43.44 -0.15 (-0.34%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

GSK $43.44 -0.34%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $43.68
Previous Close $43.59
Daily Range $43.37 - $43.71
52-Week Range $41.19 - $49.24
Market Cap $94.3B
P/E Ratio 14.98
Dividend (Yield) $2.37 (5.7%)
Ex-Dividend Date
Dividend Pay Date
08/12/15
10/01/15
Volume 4,247,055
Average Daily Volume 4,169,068
Current FY EPS $2.44

Sector

Healthcare

Industry

Drug Makers

GlaxoSmithKline (GSK) Description

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products. Website: http://www.gsk.com/

News & Commentary Rss Feed

3 Questions GlaxoSmithKline Investors Want Answered on July 29

Pharmaceutical giant GlaxoSmithKline is slated to report its second-quarter results on July 29. Here are three questions investors want answered in Glaxo's report.

Theravance: On Track To Deliver Rising Dividends

Pre-Market Most Active for Jul 31, 2015 : MFG, NVO, GSK, NOK, CCE, RCL, FEYE, INTC, HOLX, QQQ, GPRO

Pre-Market Most Active for Jul 31, 2015 : MFG, NVO, GSK, NOK, CCE, RCL, FEYE, INTC, HOLX, QQQ, GPRO, XIV

Theravance's Q2 Loss Wider-than-Expected, Revenues Miss - Analyst Blog

Glaxo Up on Q2 Earnings Beat, Revenues Rise, View Same - Analyst Blog

GlaxoSmithKline (GSK) Earnings Report: Q2 2015 Conference Call Transcript

Gilead Beats And Raises Again: Why I've Stayed Overweight

Pre-Market Most Active for Jul 30, 2015 : NOK, FB, GSK, SGYP, ALU, OWW, WFM, BAC, HOLX, LINE, FCAU,

Pre-Market Most Active for Jul 30, 2015 : NOK, FB, GSK, SGYP, ALU, OWW, WFM, BAC, HOLX, LINE, FCAU, CTRP

GlaxoSmithKline Plc (GSK) Andrew P. Witty on Q2 2015 Results - Earnings Call Transcript

3 Stocks Driving The Drugs Industry Higher

Glaxo (GSK) Beats on Q2 Earnings, Revenues Up Y/Y - Tale of the Tape

See More GSK News...

GSK's Top Competitors

GSK $43.44 (-0.34%)
Current stock: GSK
JNJ $100.21 (0.37%)
Current stock: JNJ
NVS $103.75 (0.55%)
Current stock: NVS
RHHBY $36.11 (0.17%)
Current stock: RHHBY